Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsAlbumin and multiple sclerosisSystematic review of clinical practice guidelines related to multiple sclerosisIntrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatmentsOligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeBiomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.Reporting cerebrospinal fluid data: knowledge base and interpretation software.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry.Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.Chronic cerebrovascular dysfunction after traumatic brain injuryValidation of serum markers for blood-brain barrier disruption in traumatic brain injury.Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.Multiple sclerosis: the disease and its manifestations.Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.Will Rogers phenomenon in multiple sclerosis.Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.Pharmacokinetics and bioavailability of a therapeutic enzyme (idursulfase) in cynomolgus monkeys after intrathecal and intravenous administration.Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy.Detection of oligoclonal IgG kappa and IgG lambda bands in cerebrospinal fluid and serum with Hevylite™ antibodies. comparison with the free light chain oligoclonal pattern.CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients.Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.Fluid biomarkers in Alzheimer disease.Use of immunoassays in neurological diagnosis and research.Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencingThe neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatmentMcDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic SensitivityMultiple sclerosis in malaysia: demographics, clinical features, and neuroimaging characteristicsAlterations in Cerebrospinal Fluid in Patients with Bipolar Syndromes.
P2860
Q21093230-579A654B-CDA1-4211-B537-A0FDF323258EQ26749307-6FA09AB2-D21D-4E9F-8FEC-5EA1E4208721Q26824425-6717AA59-8476-4B47-8665-90D03645681CQ26851694-550EAE8B-BE8F-42C5-AB21-89489F981315Q29417120-72AF2411-A0E1-4F13-A09F-B3285567B8E1Q30371412-CEF35D34-2C2F-41A1-B62D-7BD029B3A715Q30651551-72E3761B-B50A-4A2D-B67D-BBCE6B114A97Q30653455-AD4B7EE6-5BC5-4549-8979-713B37B087E0Q30785267-2876D33F-A93F-4F54-954F-1C607E9DF2A7Q31109918-5EA9AEE9-99FF-453A-A16F-403A0CEB25C9Q33187603-39C5475A-871D-4CB0-8E86-3A9CDFDCF459Q33633462-8A99DDE9-C451-447A-BCB2-20C1D90DE62FQ33657728-33A05D40-45EC-4B79-B2D6-916C31E7A213Q33722349-CDCCA1CC-0B16-47EF-AD24-0EC1805F3911Q33731693-3A9EE0D3-EEAD-4992-B733-FAEE785DF0BAQ33765725-6476174F-C958-4FC4-BD9F-7EFB7F783B7DQ33792114-6FB79E81-25DA-4141-8C72-577689EBE22BQ33798227-0611D32E-9B1A-4A6D-9690-890A75B3FE2CQ34353773-8E6F382A-18F0-415C-BFFC-91D63A85F169Q34558843-01134989-B7D3-4D65-9AF6-47C3764DA357Q34805875-62D109BB-DF69-4403-B992-0AD0D389F942Q35041447-4A4EB516-3CEA-436F-91EA-1D6C2D7D927EQ35138419-CEA75E4C-36F4-4DCF-8740-7407130AFDF3Q35166138-05CAED15-EA5E-42BC-B302-0BC3127E9CCEQ35250761-72AFC05A-2FE8-4B49-B711-36D85E73086AQ35377133-B865CD5D-DAF5-4E8C-910B-2DEC868D6499Q35452693-C02F3FCF-FEB8-4A9F-87B8-34C41A3AE998Q35835868-C70CBB94-7114-42DE-B317-E4B4ACF0DDA6Q35840859-5AA54D10-D9C5-464A-8762-2A76935FC192Q35864847-25139887-C125-4D48-874D-2E8E09368A6FQ36043407-C73F2DFF-DA8A-4C4E-88C3-E8CE514C9411Q36142649-AF64459F-22E1-4F8D-87AF-128ECAF12C07Q36186513-7CCB0116-6E90-4A76-B4B2-D51992E6953CQ36273707-615588AB-C484-436D-878A-4AB06C4B1E19Q36432500-5B5211F9-28EE-47F7-B4C0-F123FB3596D5Q36433030-BF11D524-D3C2-4E07-9B91-53C7FECD968FQ36560406-3476E88B-ACC0-40BF-BD58-2C4D853C7931Q37286668-3FF91968-23EF-4BE5-A0A0-C92B61C4815BQ37465979-73FD7699-679D-4BBE-8EF3-9F13715CD581Q37483978-8BA804EA-23B6-4066-8D40-0BBBF2AD34F0
P2860
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
@ast
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
@en
type
label
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
@ast
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
@en
prefLabel
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
@ast
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
@en
P2093
P2860
P356
P1476
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
@en
P2093
Alvarez-Cermeño J
Andersson M
Bernardi G
Frederiksen J
Fredrikson S
Grimaldi LM
Grønning M
P2860
P304
P356
10.1136/JNNP.57.8.897
P407
P577
1994-08-01T00:00:00Z